208 related articles for article (PubMed ID: 34716429)
1. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.
Tang SC; Lion Q; Peulen O; Chariot P; Lavergne A; Mayer A; Fuster PA; Close P; Klein S; Florin A; Büttner R; Nemazanyy I; Shostak K; Chariot A
Oncogene; 2022 Jan; 41(2):173-190. PubMed ID: 34716429
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
3. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
[TBL] [Abstract][Full Text] [Related]
4. COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.
Shao J; Teng Y; Padia R; Hong S; Noh H; Xie X; Mumm JS; Dong Z; Ding HF; Cowell J; Kim J; Han J; Huang S
Neoplasia; 2013 Sep; 15(9):1075-85. PubMed ID: 24027432
[TBL] [Abstract][Full Text] [Related]
5. The ubiquitin ligase COP1 regulates cell cycle and apoptosis by affecting p53 function in human breast cancer cell lines.
Ka WH; Cho SK; Chun BN; Byun SY; Ahn JC
Breast Cancer; 2018 Sep; 25(5):529-538. PubMed ID: 29516369
[TBL] [Abstract][Full Text] [Related]
6. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
7. MiR-301a-3p Suppresses Estrogen Signaling by Directly Inhibiting ESR1 in ERα Positive Breast Cancer.
Lettlova S; Brynychova V; Blecha J; Vrana D; Vondrusova M; Soucek P; Truksa J
Cell Physiol Biochem; 2018; 46(6):2601-2615. PubMed ID: 29763890
[TBL] [Abstract][Full Text] [Related]
8. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
9. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
10. COP1D, an alternatively spliced constitutive photomorphogenic-1 (COP1) product, stabilizes UV stress-induced c-Jun through inhibition of full-length COP1.
Savio MG; Rotondo G; Maglie S; Rossetti G; Bender JR; Pardi R
Oncogene; 2008 Apr; 27(17):2401-11. PubMed ID: 17968316
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor SAHA induces ERalpha degradation in breast cancer MCF-7 cells by CHIP-mediated ubiquitin pathway and inhibits survival signaling.
Yi X; Wei W; Wang SY; Du ZY; Xu YJ; Yu XD
Biochem Pharmacol; 2008 May; 75(9):1697-705. PubMed ID: 18342836
[TBL] [Abstract][Full Text] [Related]
12. Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.
Okada M; Ohtake F; Nishikawa H; Wu W; Saeki Y; Takana K; Ohta T
Mol Endocrinol; 2015 Nov; 29(11):1646-57. PubMed ID: 26389696
[TBL] [Abstract][Full Text] [Related]
13. The Ubiquitin Ligase COP1 Promotes Glioma Cell Proliferation by Preferentially Downregulating Tumor Suppressor p53.
Zou S; Zhu Y; Wang B; Qian F; Zhang X; Wang L; Fu C; Bao H; Xie M; Gao S; Yu R; Shi H
Mol Neurobiol; 2017 Sep; 54(7):5008-5016. PubMed ID: 27534417
[TBL] [Abstract][Full Text] [Related]
14. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
Yuan L; Li X; Yang H; Li H
Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
[TBL] [Abstract][Full Text] [Related]
15. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
[TBL] [Abstract][Full Text] [Related]
16. 14-3-3sigma exerts tumor-suppressor activity mediated by regulation of COP1 stability.
Su CH; Zhao R; Zhang F; Qu C; Chen B; Feng YH; Phan L; Chen J; Wang H; Wang H; Yeung SC; Lee MH
Cancer Res; 2011 Feb; 71(3):884-94. PubMed ID: 21135113
[TBL] [Abstract][Full Text] [Related]
17. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
[TBL] [Abstract][Full Text] [Related]
18. Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.
Ito I; Hanyu A; Wayama M; Goto N; Katsuno Y; Kawasaki S; Nakajima Y; Kajiro M; Komatsu Y; Fujimura A; Hirota R; Murayama A; Kimura K; Imamura T; Yanagisawa J
J Biol Chem; 2010 May; 285(19):14747-55. PubMed ID: 20207742
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA H19 Acts as an Estrogen Receptor Modulator that is Required for Endocrine Therapy Resistance in ER+ Breast Cancer Cells.
Basak P; Chatterjee S; Bhat V; Su A; Jin H; Lee-Wing V; Liu Q; Hu P; Murphy LC; Raouf A
Cell Physiol Biochem; 2018; 51(4):1518-1532. PubMed ID: 30497079
[TBL] [Abstract][Full Text] [Related]
20. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
